NCT03613844View on ClinicalTrials.gov

DHA Brain Delivery Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

May 16, 2024

Study Completion Date

May 16, 2024

Conditions
Brain DHA Delivery and Alzheimer's Disease Risk
Interventions
DRUG

DHA

DHA supplementation

DRUG

Placebo

Placebo for DHA

Trial Locations (1)

90033

USC Keck School of Medicine, Los Angeles

Sponsors
All Listed Sponsors
collaborator

Huntington Medical Research Institutes

OTHER

collaborator

National Institute on Aging (NIA)

NIH

collaborator

Alzheimer's Drug Discovery Foundation

OTHER

lead

University of Southern California

OTHER